Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial

BACKGROUND: Intensive glucose control reduces the risk for microvascular complications in type 2 diabetes (T2DM). Recently, sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to exert renoprotection beyond glycemic control, although their effects on the organs are not well known. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Satirapoj, Bancha, Korkiatpitak, Pattharamon, Supasyndh, Ouppatham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Sglt2 Inhibitors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543969/
https://www.ncbi.nlm.nih.gov/pubmed/31198224
http://dx.doi.org/10.1093/ckj/sfy122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543969/
https://www.ncbi.nlm.nih.gov/pubmed/31198224
http://dx.doi.org/10.1093/ckj/sfy122

Ejemplares similares